IT:XTLB XTL Biopharmaceuticals Ltd.

XTL Biopharmaceuticals Ltd is engaged in the acquisition & development of pharmaceutical drugs for the treatment of unmet medical needs, currently for the treatment of schizophrenia and Hepatitis C. It has also developed a home therapeutic device.This company has ADRs that trade in the U.S. as the symbol XTLB.

4.30 ILS
As of 03/22/2023

---

Security Information

---

Category1:  Global Equity
Category2:  Common stocks
Category3:  Developed markets ex-US
GICS sector:  Health Care
Industry:  
Index country:  Israel
Country of incorporation:  Israel
IPO date:  01/01/1900
Stock exchange:    Tel Aviv Stock Exchange
Exchange country:   Israel
Market cap:   0 ILS
Current dividend yield:   0.00%
Sedol: